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SUMMARY
Introduction Oxidative stress and antioxidants play an important role in the pathogenesis of inflam-
matory disease, including chronic periodontitis (CP). Saliva contains enzymatic (glutathione peroxidase 
– GPx, superoxide dismutase – SOD, etc.) and non-enzymatic (albumin – ALB, uric acid – UA, glutathione, 
etc.) antioxidants.
Objective The aims of this study were to investigate: a) level of SOD, GPx, UA, ALB and total antioxidative 
status (TAS) of saliva in CP patients before and after non-surgical treatment, and b) correlations between 
clinical periodontal parameters and levels of salivary antioxidants.
Methods Saliva was collected from 21 CP patients before and after non-surgical treatment. The condi-
tion of periodontium was assessed by plaque index, gingival index, bleeding on probing, probing depth 
and clinical attachment loss. Level of investigated antioxidants (except GPx) and TAS was determined 
using colorimetric method and commercial kits. GPx activity was determined using UV method and 
commercial kits.
Results After the treatment significant increase of UA, ALB, Gpx, TAS was detected (p<0.01) and decrease 
of SOD activity (p>0.05). A significant correlation was observed between GPx and PI (r=0.575, p=0.008), 
SOD and GI (r=0.525, p=0.017) before therapy, and SOD and bleeding on probing (BP) (r=0.59, p=0.006), 
TAS and BP (r=0.453, p=0.045) after therapy.
Conclusion These data suggest that levels of salivary antioxidants generally increase after non-surgical 
periodontal treatment. Correlation between some clinical periodontal parameters and level of salivary 
antioxidants was found.
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Chronic periodontitis is the most prevalent 
oral inflammatory disease. It appears as a re-
sult of imbalance between bacterial coloniza-
tion of the oral environment and host immune 
defense. As a part of body immune response 
inflammatory mediators are released allowing 
chemotaxis of immune cells in place of inflam-
mation. Polymorphonuclear leukocytes (PMN) 
are the first line defense of oral tissues from 
pathogenic microorganisms. Interaction of 
leukocytes and bacteria trigger the biochemi-
cal and physiological processes that cause the 
host to neutralize pathogens, but also possible 
damage to local tissues. Polymorphonuclear 
leukocytes induced by pathogens are charac-
terized by increased consumption of oxygen 
(respiratory burst) i.e. increasing the produc-
tion of free radicals (superoxide anion, hydro-
gen peroxide, hydroxyl radical, etc.). Released 
radicals, by oxidative mechanism distort the 
structure of bacterial cell membrane and thus 
kill bacteria. However, during the defense re-
action, especially under the conditions of the 
overproduction of radicals can lead to oxida-
tive modification of various host biomole-
cules and damage oral tissue cells, as a kind 
of collateral damage. Saliva contains enzymatic 
(superoxide dismutase – SOD, glutathione 
peroxidase – GPx, peroxidase, catalase, etc.) 
and non-enzymatic antioxidants (uric acid – 
UA, albumin – ALB, glutathione, vitamins A, 
C, etc.) which neutralize free radicals. It has 
been clamed that there is significant decrease 
in the concentration of antioxidants in saliva 
of periodontal patients comparing to healthy 
individuals [1-5]. There are a lot of systemic 
disorders giving oral manifestations based on 
imbalance between free radicals and antioxi-
dants, with consequential destruction of host 
tissue as a result of oxidative stress (diabetes 
mellitus, atherosclerosis, multiple sclerosis, 
etc). Thereby, recent research is very oriented 
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to determine, not only periodontal biomarkers, but also 
the risk markers of systemic diseases giving oral manifesta-
tions, which reflect disease onset, progression and therapy 
outcome, with emphasis on available and low invasive pro-
cedures.
OBJECTIVE
The aim of the study was to investigate the influence of 
non-surgical periodontal treatment on salivary antioxi-
dants.
METHODS
This controlled clinical study was conducted at the Clinic 
of Periodontology and Oral Medicine, and biochemical 
research at the Biochemical Laboratory of the Faculty of 
Dental Medicine, University of Belgrade. The protocol was 
approved by the Ethic Committee of the Faculty of Dental 
Medicine, University of Belgrade.
Patient selection
The study group consisted of 21 systemically healthy non-
smokers aged between 25 and 55 years with chronic peri-
odontitis (CP) in the period of exacerbation (radiographic 
evidence of generalized alveolar bone loss >30%, presence 
of at least one pocket with PPD >5 mm per quadrant with 
positive bleeding on probing – BOP). Exclusion criteria 
were pregnant or lactating women, use of food supple-
ments, such as vitamin C and E supplements over the pre-
vious three months or some restrictive diet.
Treatment protocol
All participants were evaluated clinically and radiographi-
cally at the first visit. If they fulfilled the inclusion criteria 
they were informed about the study and gave a written 
consent. On the second (baseline) visit the first saliva sam-
ple was collected (see sampling technique) before clinical 
measurements in order to avoid any potential contamina-
tion of the specimen by blood originating from periodon-
tal pockets after provocation with clinical measurements. 
After sampling, full-mouth clinical measurements (see 
clinical measurements) were performed and recorded into 
the patient’s study chart. Non-surgical periodontal treat-
ment included oral hygiene instructions and full-mouth 
scaling and root planing. Treatment was performed by the 
same periodontist under local anesthesia aiming to avoid 
painful experience during periodontal debridement that 
included scaling and root planing using ultrasonic scaler 
and Gracey curettes. A control visit was scheduled two 
months after treatment. The second saliva sample was 
collected and the same clinical measurements were per-
formed and recorded in the chart.
Clinical measurements
The following clinical parameters were assessed at six sites 
around each present tooth for the whole mouth excluding 
third molars by a single investigator. Clinical parameters 
used in this study were gingival index (GI) [6], plaque in-
dex (PI) [6], bleeding on probing (BP) [7], probing depth 
(PPD) distance from the gingival margin to the location 
of the tip of the graduated periodontal probe (North Caro-
lina-Hu-Friedy, Chicago, IL, USA) inserted in the pocket 
with moderate probing force and clinical attachment level 
(CAL) distance from the cemento-enamel junction to the 
location of the inserted probe tip.
Sampling technique
The samples for biochemical analyses were collected at 
baseline visit and two months after finished periodontal 
treatment. Unstimulated whole saliva (2 ml) was collect-
ed from each subject by the Salivette (Salivette, Sarstedt, 
Germany) between 9.00-10.00 a.m. The participants were 
requested not to eat or drink anything except water on 
the morning before sampling. This was to ensure that the 
variability in salivary flow and composition be minimized 
due to diurnal variation. The subject was asked to rinse the 
mouth with distilled water thoroughly to remove any food 
debris. After that the Salivette was placed in the sublingual 
area for 1 min. the collected samples were immediately 
transported to the laboratory, and were centrifuged at 4000 
g for 10 minutes and frozen at -80°C until analysis.
Biochemical analyses
SOD, ALB, UA, and total antioxidant status (TAS) were 
determined using the colorimetric method and commer-
cial kits Ransod (Randox Laboratories Ltd., United King-
dom), Albumin (Human Gesellschaft fűr Biochemica und 
Diagnostica mbH, Germany), Uric Acid liquicolor (Hu-
man Gesellschaft fűr Biochemica und Diagnostica mbH, 
Germany) and TAS (Randox Laboratories Ltd., United 
Kingdom). Glutathione peroxidase activity was deter-
mined using UV method and commercial kit Ransel (Ran-
dox Laboratories Ltd., United Kingdom).
Statistical analysis
Statistical analysis was performed using commercial statis-
tical software (SPSS 16.0, Inc., Chicago, IL, USA). Biomar-
kers were expressed as follows: ALB levels as g/L, uric acid 
and TAS levels as µmol/L, GPX and SOD levels as IU/L. 
Secondary outcome variables included CAL, GI and PI. 
Clinical variables (GI, PI, PPD and CAL) were calculated 
by the patient and visit. All data were expressed as mean 
and standard deviation.
Kolmogorov-Smirnov test was performed for all con-
tinuous variables to assess normality of data. In the assess-
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ment of correlation between parameters, Pearson’s correla-
tion coefficient was used. Demographic data (gender and 
age) as nominal variables were analyzed using chi-square 
test. Statistical significance was established at the 95% con-
fidence level.
RESULTS
In this study 21 participants were included, 14 male 
(66.67%) and 7 female (33.33%), aged 39.2±11.5 years.
The values of clinical parameters except CAL showed 
a significant decrease after therapy (Table 1). Also, sig-
nificant increase of ALB and UA concentrations and GPx 
activity as well as TAS (p<0.01) was shown in this study. 
On the other hand SOD activity was decreased after non-
surgical periodontal treatment, but it was not statistically 
significant (p>0.05) (Table 2).
In this study correlations between biochemical and 
clinical parameters were analyzed. A significant positive 
correlation was observed between GPx and PI (r=0.575, 
p=0.008) (Figure 1) and negative correlation between SOD 
and GI (r=-0.525, p=0.017) (Figure 2) before therapy, as 
well as a positive correlation between SOD and BP (r=0.59, 
p=0.006) (Figure 3), TAS and BP (r=0.453, p=0.045) (Fi-
gure 4) after therapy.
DISCUSSION
Salivary antioxidants protect the integrity of oral tissues by 
neutralizing free radicals. Many studies have shown that 
Table 1. Clinical parameters in chronic periodontitis patients before 
and after non-surgical periodontal treatment (mean ±SD)
Parameter Before After p
PI 1.39±0.55 0.36±0.30 0.01
GI 1.96±0.41 0.55±0.24 0.01
BP 1.81±0.52 0.43±0.19 0.01
PD 3.40±0.66 2.02±0.54 0.01
CAL 2.95±0.99 2.93±1.01 0.185
PI – plaque index; GI – gingival index; BP – bleeding on probing; PD – probing 
depth; CAL – clinical attachment loss; SD – standard deviation
Table 2. Biochemical parameters in chronic periodontitis patients 
before and after non-surgical periodontal treatment (mean ±SD)
Parameter Before After p
UA (µmol/l) 153.95±41.87 198.43±87.74 0.01
ALB (g/l) 1.31±0.07 1.43±0.11 0.01
GPx (IU/l) 1842.95±157.76 3310.75±169.24 0.01
SOD (IU/l) 0.45±0.12 0.39±0.24 >0.05
TAS (µmol/l) 0.40±0.24 0.66±0.35 0.01
UA – uric acid; ALB – albumin; GPx – gluthatione peroxidase; SOD – superoxide 
dismutase; TAS – total antioxidative status 
Figure 2. Correlation between superoxid dismutase (SOD) and gin-
gival index (GI) in chronic periodontitis patients before non-surgical 
periodontal treatment
Figure 4. Correlation between total antioxidant status (TAS) and 












GI before: SOD before: r=0.5254, p=0.0174
BP after
BP after: TAS after: r=0.4534, p=0.0447
Figure 1. Correlation between plaque index (PI) and glutathione 
peroxidase (GPx) in chronic periodontitis patients before non-surgical 
periodontal treatment










PI before: GPx before: r=0.5747, p=0.0080
PI before
Figure 3. Correlation between superoxide dismutase (SOD) and 
bleeding on probing (BP) in chronic periodontitis patients after non-
surgical periodontal treatment
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disruption of relations of free radicals and antioxidants 
play an important role in the pathogenesis of inflamma-
tory diseases of oral tissues. Most authors compared the 
levels of antioxidants in the saliva of CP patients, as the 
most common oral inflammatory disease, with their levels 
in individuals with the clinically healthy periodontium [2, 
8, 9]. In recent studies the levels of antioxidants in the sa-
liva of CP patients before and after the therapy have been 
compared [10, 11].
UA is the most common antioxidant of saliva. In this 
study, conducted after the non-surgical therapy of peri-
odontitis, the concentration of this antioxidant increased 
significantly. Results of previous studies indicated simi-
lar results. In an extensive study involving 129 subjects 
in whom periodontal health was evaluated by CPITN 
(Community Periodontal Index of Treatment Needs), a 
direct proportion between the level of UA and CPITN was 
found. The concentrations of uric acid in patients with 
high values of CPITN index (diseased periodontal tissue) 
were significantly lower than in those with low values of 
this index [12]. The aforementioned research provided in-
formation of lower concentration of uric acid in women. 
The level of UA in our study was also lower in women than 
in men but the difference did not reach statistical impor-
tance. A study conducted on patients with periimplantitis 
a significantly lower concentration of uric acid in saliva 
was found than in patients who had implants but without 
periimplantitis [13]. A study involving 17 patients with CP 
(pocket depth ≥3 mm) and 20 individuals with clinically 
healthy periodontal tissue failed to find significant differ-
ence in the concentration of UA between CP patients and 
healthy individuals [14].
Non-enzymatic salivary antioxidant ALB is the main 
protein of blood plasma. This protein is able to neutralize 
the peroxide radical, binds free fatty acids and thus protects 
against lipid peroxidation. In the study, conducted after the 
completion of non-surgical therapy, statistically significant 
increase in ALB concentration in the saliva was found. It was 
found that albumin in saliva of patients with chronic peri-
odontal disease does not originate from the salivary glands 
than from plasma [9, 15]. This research is pointing out that 
the concentration of albumin, in the saliva of CP patients is 
significantly lower than in individuals with a healthy peri-
odontium [16]. A study involving 26 subjects (12 smokers 
and 14 nonsmokers) with CP shows an increase in albumin 
concentration after non-surgical treatment. Many studies 
have shown the decrease in the concentration of ALB with 
deterioration of periodontal tissue [12, 14, 17, 18].
GPx has a primary role in neutralizing hydrogen per-
oxide and the prevention of H2O2-dependent production 
of free radicals [19]. Our findings showed that after imple-
menting non-surgical treatment of periodontal disease, 
a statistically significant increase in GPx activity was 
noticed. These results are consistent with some previous 
studies. There is a considerable diversity of results in the 
researches that examined GPx activity in saliva, and its role 
in the development of periodontitis. Studies that have ex-
amined GPx activity both in saliva and gingival cervicular 
fluid (GCF) found more convincing change in GPx activity 
in GCF than in saliva [20, 21]. During the exacerbation 
of inflammatory processes in the periodontal tissue, the 
proportion of GCF in the mixed saliva increases signifi-
cantly. Our study included CP patients with symptoms 
of exacerbation. Non-surgical therapy led to a significant 
reduction in periodontal tissue inflammation which was 
detected by changes in clinical parameters in our study. 
This finding may explain the increase in GPx activity after 
therapy. Similar results were obtained by other authors 
[10]. At the same time other studies show an increase in 
GPx activity in saliva in patients with chronic periodontitis 
compared to individuals with the clinically healthy peri-
odontium [22]. The authors of these studies explain this 
phenomenon with antioxidant compensatory mechanism 
that occurs in response to the increase of organic peroxide 
under the action of free radicals in the periodontal tissue. 
In addition to our results there are studies that have exam-
ined the activity of GPx in the saliva of individuals whose 
general health facilitates occurrence of the condition caus-
ing a more extensive inflammation of the periodontal tis-
sue (antiepileptic drugs, pregnancy, etc.) and which have 
found increasing GPx activity in saliva after treatment of 
periodontitis [20, 23, 24].
SOD catalyzes the dismutasion reaction of O2 into hy-
drogen peroxide. Since SOD accelerates the creation of 
H2O2, it must interact with enzymes such as GPx, which 
removes H2O2. This is necessary because the accumula-
tion of substances with OH group may be more dangerous 
than substances with O2 [19, 24, 25]. In our study, after 
treatment of periodontitis, SOD activity was reduced, but 
this reduction was not statistically significant. Bacterial 
lipopolysaccharide stimulates the release of O2 from tissue 
fibroblasts during inflammation [26]. Increased creation 
of O2 can lead to an increase in SOD activity in order to 
establish a balance between oxidative stress and antioxi-
dant protection. Also, increased activity of SOD, that as a 
final result of its reactions has the creation of H2O2, for the 
same reasons can lead to an increase in GPx activity, which 
eliminates H2O2, hence the increase in GPx activity after 
the therapy. Conducted surveys using standard deviation 
have found a significant and progressive reduction of SOD 
activity with increasing depth of periodontal pockets [27]. 
Studies dealing with measuring the activity of antioxidant 
enzymes in plasma, erythrocytes and gingival tissues of pa-
tients with chronic periodontitis and those with clinically 
healthy periodontal tissue showed a significantly reduced 
activity in all tested substrates in patients with the clinical-
ly healthy periodontal tissue. The same study found a re-
duced activity of GPx in CP patients. GPx should remove 
products of SOD catalyzed reactions [28]. Some studies 
suggest reduced activity of SOD in patients with chronic 
periodontitis compared to those with the clinically healthy 
periodontal tissue [29, 30]. In a study that had a similar 
design as ours, the SOD activity was significantly higher 
after the therapy of CP [31]. The diversity of the results 
of various studies on the activity of salivary enzymes can 
be explained by a rather difficult process of determining 
these enzymes in saliva when compared to blood. This is 
due to the lack of diagnostic tests for saliva.
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The subject of this and many previous studies was the 
analysis of the total antioxidant capacity of saliva (TAS) 
of CP patients. In our study, after non-surgical treatment 
of CP, a statistically significant increase of saliva TAS was 
found. This result is consistent with results from the litera-
ture [2, 5] and with the data of this study that was obtained 
for the concentration of uric acid which represented 70% 
of the antioxidant capacity of saliva.
In this study, the correlation of clinical parameters with 
biochemical parameters, before and after the therapy of CP 
was also examined. Before therapy a positive correlation 
was established between PI and GPx activity, and negative 
correlation between BP and SOD activity. After treatment 
we found a positive correlation between TAS and BP, SOD 
and BP. Only a few previous researches dealt with the cor-
relation between antioxidant capacity of saliva and clinical 
parameters of periodontal health.
The study that included CP patients (19) and individu-
als with the clinically healthy periodontium (8) focused on 
the correlations between GPx activity in GCF and clinical 
indicators of periodontal tissue: PI, GI, probing pocket 
depth and the level of CAL. Positive correlation between 
GPx activity and all of the observed clinical parameters 
was found [32]. Differences from the results of our study 
originate from the fact that, as shown by many studies, 
the activity of GPx in GCF is higher than in saliva. In the 
study of TAS in the saliva and serum from CP patients no 
statistically significant correlations between biochemical 
and clinical parameters were found [2]. The study, which 
examined the correlations GPx activity in saliva of CP 
patients before and after therapy and clinical periodontal 
parameters (PI, GI, BP, PD, CAL) showed a statistically 
significant correlation. [10]. The average values of GPx 
activity in aforementioned study were much higher than in 
our study, probably due to different collection and storage 
of saliva even though in both studies mixed unstimulated 
saliva was used.
CONCLUSION
The importance of such studies could be in the use of sa-
liva as a valid diagnostic fluid in monitoring periodontal 
disease, due to the fact indicated by numerous studies re-
porting that the secretion is in continuous and intimate 
contact with tissues of the oral environment, thus accu-
rately reflecting all events in them, such as physiological 
and pathological, as well as those on the cellular molecular 
level.
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КРАТАК САДРЖАЈ
Увод Ок си да тив ни стрес и ан ти ок си дан си игра ју ва жну 
уло гу у па то ге не зи за па љењ ских обо ље ња, укљу чу ју ћи и 
хро нич ну па ро дон то па ти ју. Пљу вач ка са др жи ен зим ске ан-
ти ок си дан се, као што су глу та тион-пе рок си да за (GPx) и су-
пер ок сид-ди сму та за (SOD), и не ен зим ске ан ти ок си дан се, по-
пут ал бу ми на (ALB), мо краћ не ки се ли не (UA), глу та ти о на итд.
Циљ ра да Циљ ис тра жи ва ња био је да се ис пи та ју ни вои 
SOD, GPx, UA и ALB и утвр ди уку пан ан ти ок си дант ни ста тус 
пљу вач ке (TAS) код осо ба с хро нич ном па ро дон то па ти јом 
пре и по сле ка у зал не те ра пи је, те уста но ве ко ре ла ци је из-
ме ђу кли нич ких по ка за те ља ста ња па ро дон ци ју ма и ни воа 
ан ти ок си дан са у пљу вач ки.
Ме то де ра да Пљу вач ка је са ку пље на од 21 па ци јен та с хро-
нич ном па ро дон то па ти јом пре и по сле ка у зал не те ра пи је. 
Ста ње па ро дон ци ју ма је про це њи ва но по мо ћу: плак-ин дек-
са (PI), гин ги вал ног ин дек са (GI), ин дек са кр ва ре ња гин ги ве 
(BP), ду би не па ро дон тал ног џе па и ни воа при пој ног епи те ла. 
Ни во ис пи ти ва них ан ти ок си дан са (осим GPx) и TAS од ре ђи-
ван је по мо ћу ко ло ри ме триј ске ме то де и ко мер ци јал них 
ре а ген са. GPx је од ре ђи ван при ме ном УВ ме то де и ко мер-
ци јал них ре а ген са.
Ре зул та ти На кон те ра пи је уста но вље ни су зна чај но по-
ве ћа ње кон цен тра ци је UA, GPx и TAS (p<0,01) и сма ње ње 
ак тив но сти SOD (p>0,05). При ме ће на је и зна чај на ко ре ла-
ци ја из ме ђу GPx и PI (r=0,575; p=0,008), те SOD и GI (r=0,525; 
p=0,017) пре те ра пи је, од но сно SOD и BP (r=0,59; p=0,006), 
као и TAS и BP (r=0,453; p=0,045) по сле ње.
За кљу чак До би је ни на ла зи по ка зу ју да се ни вои ан ти ок-
си дан са у пљу вач ки по ве ћа ва ју на кон ка у зал не те ра пи је 
па ро дон то па ти је. Уоче не су по зи тив не ко ре ла ци је из ме ђу 
кли нич ких по ка за те ља ста ња па ро дон ци ју ма и ис пи ти ва них 
кон цен тра ци ја ан ти ок си дан са у пљу вач ки.
Кључ не ре чи: пљу вач ка; ан ти ок си дан си; мо краћ на ки се ли-
на; ал бу мин; глу та тион-пе рок си да за; су пер ок сид-ди сму та за; 
те ра пи ја хро нич не па ро дон то па ти је
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